Advaxis, Inc., 28 Jul 2017 Have you seen the latest clinical data published on axalimogene filolisbac, our lead product candidate for HPV-related cancers?
Advaxis, Inc., 21 Jul 2017 Really happy and proud to share this recently published peer reviewed paper on our leading product candidate, axalimogene…